Rock Springs Capital Management LP Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$4.0B
Holdings
135
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (135 positions)
| Stock | Value |
|---|---|
AGLAGILON HEALTH INC | $193.7M |
HUMHUMANA INC | $160.4M |
PODDINSULET CORP | $128.3M |
UNHUNITEDHEALTH GROUP INC | $122.4M |
IDXXIDEXX LABS INC | $119.7M |
ARGXARGENX SE | $110.4M |
NBIXNEUROCRINE BIOSCIENCES INC | $103.6M |
AFWALIGN TECHNOLOGY INC | $94.4M |
HCAHCA HEALTHCARE INC | $94.0M |
ISRGINTUITIVE SURGICAL INC | $90.1M |
HZNPHORIZON THERAPEUTICS PUB L | $78.5M |
AGIOAGIOS PHARMACEUTICALS INC | $77.6M |
EVHEVOLENT HEALTH INC | $76.9M |
PCRXPACIRA BIOSCIENCES INC | $76.3M |
IMCRIMMUNOCORE HLDGS PLC | $76.3M |
RAREULTRAGENYX PHARMACEUTICAL IN | $74.7M |
EWEDWARDS LIFESCIENCES CORP | $70.2M |
IRTCIRHYTHM TECHNOLOGIES INC | $68.7M |
ACRSACLARIS THERAPEUTICS INC | $66.6M |
FRPTFRESHPET INC | $60.8M |
2L9BLUEPRINT MEDICINES CORP | $60.5M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $60.3M |
BAXBAXTER INTL INC | $58.2M |
SWAVUSDSHOCKWAVE MED INC | $56.3M |
KRTXKARUNA THERAPEUTICS INC | $54.8M |
ALNYALNYLAM PHARMACEUTICALS INC | $54.3M |
DC4DEXCOM INC | $53.2M |
ZLABZAI LAB LTD | $53.0M |
NVROEURNEVRO CORP | $52.2M |
ACHCACADIA HEALTHCARE COMPANY IN | $49.4M |
ASNDASCENDIS PHARMA A/S | $49.0M |
MRTXEURMIRATI THERAPEUTICS INC | $46.0M |
PENPENUMBRA INC | $45.4M |
EXASEXACT SCIENCES CORP | $39.9M |
SGENUSDSEAGEN INC | $39.0M |
—SIERRA ONCOLOGY INC | $37.7M |
MIRMMIRUM PHARMACEUTICALS INC | $36.7M |
EHCENCOMPASS HEALTH CORP | $35.7M |
WRBYWARBY PARKER INC | $35.1M |
SRPTSAREPTA THERAPEUTICS INC | $33.4M |
NVV1NOVAVAX INC | $33.0M |
KYMRKYMERA THERAPEUTICS INC | $32.0M |
ARVNARVINAS INC | $30.8M |
CNMDCONMED CORP | $30.1M |
CYTK 4 11/15/26CYTOKINETICS INC | $29.3M |
WSTWEST PHARMACEUTICAL SVSC INC | $28.4M |
CVETUSDCOVETRUS INC | $28.1M |
MDGLMADRIGAL PHARMACEUTICALS INC | $26.8M |
NVTA1EURINVITAE CORP | $26.5M |
ACCDEURACCOLADE INC | $26.4M |
—ABCAM PLC | $26.2M |
XENEXENON PHARMACEUTICALS INC | $25.8M |
PHRPHREESIA INC | $25.0M |
TVTXTRAVERE THERAPEUTICS INC | $24.5M |
PRTAPROTHENA CORP PLC | $24.3M |
HCATHEALTH CATALYST INC | $23.9M |
—PROMETHEUS BIOSCIENCES INC | $23.6M |
AURAAURA BIOSCIENCES INC | $22.2M |
BMRNBIOMARIN PHARMACEUTICAL INC | $20.4M |
LFSTLIFESTANCE HEALTH GROUP INC | $20.2M |
—CINCOR PHARMA INC | $18.1M |
RLAYRELAY THERAPEUTICS INC | $18.0M |
LUNGPULMONX CORP | $17.4M |
—OLINK HLDG AB | $17.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $17.2M |
—INTERSECT ENT INC | $15.4M |
—MERSANA THERAPEUTICS INC | $15.0M |
LEGNLEGEND BIOTECH CORP | $14.9M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $14.8M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $14.7M |
AMRNAMARIN CORP PLC | $14.5M |
NVCRNOVOCURE LTD | $14.5M |
RYTMRHYTHM PHARMACEUTICALS INC | $14.3M |
ANABANAPTYSBIO INC | $13.9M |
GHGUARDANT HEALTH INC | $13.2M |
AMLXAMYLYX PHARMACEUTICALS INC | $12.8M |
VERVVERVE THERAPEUTICS INC | $11.5M |
290ACHINOOK THERAPEUTICS INC | $11.5M |
—AMRYT PHARMA PLC | $10.8M |
FULCFULCRUM THERAPEUTICS INC | $10.3M |
—ORION ACQUISITION CORP | $9.8M |
AM6AMICUS THERAPEUTICS INC | $9.6M |
AUPHAURINIA PHARMACEUTICALS INC | $9.5M |
GRPHGRAPHITE BIO INC | $9.1M |
AKROAKERO THERAPEUTICS INC | $9.0M |
—GAMIDA CELL LTD | $8.9M |
SPROSPERO THERAPEUTICS INC | $8.6M |
XLOXILIO THERAPEUTICS INC | $8.4M |
—EPIZYME INC | $8.4M |
MGNXMACROGENICS INC | $8.2M |
GOSS 5 06/01/27GOSSAMER BIO INC | $7.7M |
—ATHIRA PHARMA INC | $7.5M |
—FUSION PHARMACEUTICALS INC | $7.4M |
CMPXCOMPASS THERAPEUTICS INC | $7.3M |
CGEMCULLINAN ONCOLOGY INC | $6.8M |
MREOMEREO BIOPHARMA GROUP PLC | $6.8M |
LPTXEURLEAP THERAPEUTICS INC | $6.3M |
EDAEDAP TMS S A | $5.9M |
NKTXNKARTA INC | $5.8M |
DSGNDESIGN THERAPEUTICS INC | $5.6M |
Page 1 of 2Next